Cubist Systematic Strategies’s Kindred Healthcare KND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-9,571
Closed -$86K 2230
2018
Q2
$86K Sell
9,571
-362
-4% -$3.24K ﹤0.01% 1578
2018
Q1
$91K Sell
9,933
-4,567
-31% -$42.3K 0.01% 1608
2017
Q4
$141K Sell
14,500
-25,728
-64% -$191K 0.01% 1628
2017
Q3
$274K Buy
40,228
+36,793
+1,071% +$313K 0.02% 1237
2017
Q2
$40K Sell
3,435
-54,290
-94% -$535K ﹤0.01% 1568
2017
Q1
$482K Buy
57,725
+56,409
+4,286% +$442K 0.03% 657
2016
Q4
$10K Buy
+1,316
New +$10.8K ﹤0.01% 1652
2016
Q2
Sell
-16,157
Closed -$200K 1992
2016
Q1
$200K Sell
16,157
-10,610
-40% -$110K 0.01% 1224
2015
Q4
$319K Sell
26,767
-9,178
-26% -$119K 0.02% 1086
2015
Q3
$566K Sell
35,945
-2,781
-7% -$56.3K 0.03% 887
2015
Q2
$786K Buy
38,726
+34,774
+880% +$796K 0.04% 703
2015
Q1
$94K Sell
3,952
-11,144
-74% -$226K ﹤0.01% 1677
2014
Q4
$274K Buy
15,096
+6,093
+68% +$121K 0.01% 1292
2014
Q3
$175K Sell
9,003
-1,106
-11% -$24.1K 0.01% 1423
2014
Q2
$234K Buy
+10,109
New +$247K 0.01% 1083

Cubist Systematic Strategies's KND Position: Q3 2018 in Review

Cubist Systematic Strategies sold out of Kindred Healthcare (KND) in Q3 2018, closing a stake of 9,571 shares — an estimated $86K sold.

Cubist Systematic Strategies first reported a position in KND in Q2 2014 and held it in 15 quarters. The position peaked at $786K in Q2 2015. 0 funds tracked by Wall St. Rank hold KND as of Q3 2018.

  • Cubist Systematic Strategies reported no remaining Kindred Healthcare position as of Q3 2018 after selling out during the quarter.
  • Cubist Systematic Strategies sold 9,571 Kindred Healthcare shares in Q3 2018, an estimated $86K.
  • Cubist Systematic Strategies first reported a position in Kindred Healthcare in Q2 2014 and held it in 15 quarters.
  • Cubist Systematic Strategies's Kindred Healthcare position peaked at $786K in Q2 2015.
  • 0 funds tracked by Wall St. Rank held Kindred Healthcare as of Q3 2018.

Based on Cubist Systematic Strategies's 13F filing for Q3 2018, filed 14 Nov 2018.